MALVERN, PA (April 10, 2018) – To further recognize exceptional, groundbreaking contributions in the area of Inflammatory Bowel Disease (IBD) research, HMP, a leading healthcare event and education company, today announced it has invited the Bruce and Cynthia Sherman Charitable Foundation to hold its annual Sherman Prize for Excellence in Crohn’s and Colitis awards presentation on December 13, 2018, the first day of HMP’s Advances in Inflammatory Bowel Diseases (AIBD) conference in Orlando, Florida.
As a family touched by Crohn’s disease, Bruce and Cynthia Sherman created the prize in 2016 as a way to increase focus on pioneering contributions in IBD. The Sherman Prize is the first award of its kind to reward healthcare providers, medical researchers, educators and public health advocates for outstanding achievements in the areas of IBD patient care, medical research, public service, and professional and public education. Two prizes of $100,000 each are awarded annually to individuals with extraordinary track records of achievement, and a $25,000 Sherman Emerging Leader Prize is awarded to an individual who demonstrates high potential.
“It is an honor to present these prestigious awards during AIBD,” said Dan Lowrie, president, Imedex, a wholly owned subsidiary of HMP, and organizer of AIBD. “AIBD and the Sherman Prize share a common goal — to advance the treatment of patients with inflammatory bowel diseases. We’re proud to host the awards and help provide Sherman Prize recipients the recognition they deserve. This Prize will surely inspire others in the field and promote even more exciting outcomes in the future.”
“We are very pleased to present this year’s awards in front of such a broad cross-section of the IBD community,” said Bruce Sherman. “It is a great opportunity for these IBD professionals to hear about pioneering research and how their peers are personally making a difference in their patients’ lives. We believe that by consistently elevating great work, we are creating a ripple effect that encourages future advances in the field and the science that could lead to a cure.”
AIBD is a three-day, multi-track, scientific conference that attracts more than 2,000 clinicians, including adult and pediatric gastroenterologists, internists, surgeons, nurse practitioners, and other allied healthcare professionals. The 17th meeting will take place December 13-15, 2018 in Orlando, Florida. To learn more about AIBD, visit advancesinibd.com.
2018 Sherman Prize recipients have not yet been selected. The Sherman Prize is accepting nominations through April 25 at shermanprize.org. Last year’s Sherman Prize honorees were Stephan R. Targan, MD, Director of the Inflammatory Bowel and Immuno-biology Research Institute at Cedars-Sinai, Los Angeles, CA, and Lee A. Denson, MD, Director of the Schubert-Martin IBD Center at Cincinnati Children’s Hospital Medical Center in Cincinnati, OH. Heidi Drescher, MMS, PA-C, of Community Physician Group, Community Medical Center in Missoula, MT, was awarded the Sherman Emerging Leader Prize. To learn more, visit shermanprize.org/prize-recipients.
HMP is the force behind Healthcare Made Practical—and is a multichannel leader in healthcare events and education, with a mission to improve patient care. The company produces accredited medical education events and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include Consultant, the monthly, award-winning journal relied upon by primary care providers; Psych Congress, the largest independent mental health meeting in the U.S.; EMS World Expo, North America's largest EMT and paramedic event; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. HMP is supported by its lead investor, Susquehanna Growth Equity, LLC (SGE). For more information, visit hmpglobal.com.
Imedex, an HMP company, is an industry leader in the creation of independent, accredited medical education for healthcare professionals. With an emphasis in oncology, hematology, and gastroenterology, the company develops high-quality scientific programming that translates the latest research into clinically relevant information. The company operates in the United States, Europe, and Asia. For more information, visit imedex.com.